BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33482392)

  • 1. The Ubiquitin E3 Ligase TRIM21 Promotes Hepatocarcinogenesis by Suppressing the p62-Keap1-Nrf2 Antioxidant Pathway.
    Wang F; Zhang Y; Shen J; Yang B; Dai W; Yan J; Maimouni S; Daguplo HQ; Coppola S; Gao Y; Wang Y; Du Z; Peng K; Liu H; Zhang Q; Tang F; Wang P; Gao S; Wang Y; Ding WX; Guo G; Wang F; Zong WX
    Cell Mol Gastroenterol Hepatol; 2021; 11(5):1369-1385. PubMed ID: 33482392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Fever with Thrombocytopenia Syndrome Virus NSs Interacts with TRIM21 To Activate the p62-Keap1-Nrf2 Pathway.
    Choi Y; Jiang Z; Shin WJ; Jung JU
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM21 Ubiquitylates SQSTM1/p62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis.
    Pan JA; Sun Y; Jiang YP; Bott AJ; Jaber N; Dou Z; Yang B; Chen JS; Catanzaro JM; Du C; Ding WX; Diaz-Meco MT; Moscat J; Ozato K; Lin RZ; Zong WX
    Mol Cell; 2016 Mar; 61(5):720-733. PubMed ID: 26942676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
    Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
    J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin.
    Hou K; Shen J; Yan J; Zhai C; Zhang J; Pan JA; Zhang Y; Jiang Y; Wang Y; Lin RZ; Cong H; Gao S; Zong WX
    EBioMedicine; 2021 Jul; 69():103456. PubMed ID: 34233258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinoma.
    Shimizu T; Inoue K; Hachiya H; Shibuya N; Aoki T; Kubota K
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):467-71. PubMed ID: 27246794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RPRD1A stabilizes NRF2 and aggravates HCC progression through competing with p62 for TRIM21 binding.
    Feng X; Jiang T; Yang C; Pang S; Ding Z; Hu H; Wang H; Dong L; Yang N
    Cell Death Dis; 2021 Dec; 13(1):6. PubMed ID: 34921137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis.
    Haque E; Karim MR; Salam Teeli A; Śmiech M; Leszczynski P; Winiarczyk D; Parvanov ED; Atanasov AG; Taniguchi H
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MOAP-1-mediated dissociation of p62/SQSTM1 bodies releases Keap1 and suppresses Nrf2 signaling.
    Tan CT; Chang HC; Zhou Q; Yu C; Fu NY; Sabapathy K; Yu VC
    EMBO Rep; 2021 Jan; 22(1):e50854. PubMed ID: 33393215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway.
    Shu B; Zhou Y; Lei G; Peng Y; Ding C; Li Z; He C
    Cancer Sci; 2024 May; 115(5):1476-1491. PubMed ID: 38475938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis.
    Zhao L; Kang M; Liu X; Wang Z; Wang Y; Chen H; Liu W; Liu S; Li B; Li C; Chang A; Tang B
    J Exp Clin Cancer Res; 2022 Nov; 41(1):330. PubMed ID: 36419136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NRF2 DLG Domain Mutations Identified in Japanese Liver Cancer Patients Affect the Transcriptional Activity in HCC Cell Lines.
    Haque E; Śmiech M; Łuczyńska K; Bouchard MF; Viger R; Kono H; Pierzchała M; Taniguchi H
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative subcellular localization of NRF2 and KEAP1 during the hepatocellular carcinoma development in vivo.
    Guerrero-Escalera D; Alarcón-Sánchez BR; Arellanes-Robledo J; Cruz-Rangel A; Del Pozo-Yauner L; Chagoya de Sánchez V; Resendis-Antonio O; Villa-Treviño S; Torres-Mena JE; Pérez-Carreón JI
    Biochim Biophys Acta Mol Cell Res; 2022 May; 1869(5):119222. PubMed ID: 35093454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC.
    Mattu S; Zavattari P; Kowalik MA; Serra M; Sulas P; Pal R; Puliga E; Sutti S; Foglia B; Parola M; Albano E; Giordano S; Perra A; Columbano A
    Cell Mol Gastroenterol Hepatol; 2022; 13(1):113-127. PubMed ID: 34530178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells.
    Inami Y; Waguri S; Sakamoto A; Kouno T; Nakada K; Hino O; Watanabe S; Ando J; Iwadate M; Yamamoto M; Lee MS; Tanaka K; Komatsu M
    J Cell Biol; 2011 Apr; 193(2):275-84. PubMed ID: 21482715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC27A5 deficiency activates NRF2/TXNRD1 pathway by increased lipid peroxidation in HCC.
    Gao Q; Zhang G; Zheng Y; Yang Y; Chen C; Xia J; Liang L; Lei C; Hu Y; Cai X; Zhang W; Tang H; Chen Y; Huang A; Wang K; Tang N
    Cell Death Differ; 2020 Mar; 27(3):1086-1104. PubMed ID: 31367013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
    Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
    Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of TRIM21 contributes to hepatocellular carcinoma carcinogenesis and indicates poor prognosis of cancers.
    Ding Q; He D; He K; Zhang Q; Tang M; Dai J; Lv H; Wang X; Xiang G; Yu H
    Tumour Biol; 2015 Nov; 36(11):8761-72. PubMed ID: 26055142
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Lu J; Ding Y; Zhang W; Qi Y; Zhou J; Xu N; Zhang Y; Xie W
    Cells; 2023 Apr; 12(9):. PubMed ID: 37174639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic NOD2 promotes hepatocarcinogenesis via a RIP2-mediated proinflammatory response and a novel nuclear autophagy-mediated DNA damage mechanism.
    Zhou Y; Hu L; Tang W; Li D; Ma L; Liu H; Zhang S; Zhang X; Dong L; Shen X; Chen S; Xue R; Zhang S
    J Hematol Oncol; 2021 Jan; 14(1):9. PubMed ID: 33413510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.